A Study of BGM0504 in Early T2DM With Obesity
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 372 participants.
Also called NCT07743983
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 372 participants
- Registry
-
NCT07743983
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07743983. Randomized; no masking; primary purpose treatment. Start 2026-09-17 (actual); primary completion 2028-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of BGM0504 in Early T2DM With Obesity
- Condition
- Type 2 Diabetes (T2DM)
- Intervention (Drug)
- BGM0504
- Intervention (Drug)
- semaglutide
- Lead sponsor
- BrightGene Bio-Medical Technology Co., Ltd.
Record details
- Record id
cardio:ct-nct07743983- Content hash
6e4454f8f5bb4678f0027795ae48d185e92f5c92706435aa6513e3c8be1581e8